Physiomics (LON:PYC) Shares Down 11.2% – Here’s Why

Shares of Physiomics Plc (LON:PYC) dropped 11.2% on Thursday . The company traded as low as GBX 0.44 and last traded at GBX 0.44. Approximately 871,681 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 6,996,127 shares. The stock had previously closed at GBX 0.50.

Physiomics Price Performance

The business has a 50 day moving average of GBX 0.40 and a 200 day moving average of GBX 0.40. The firm has a market capitalization of £1.35 million, a price-to-earnings ratio of -2.96 and a beta of 1.69.

Physiomics (LON:PYC) last announced its quarterly earnings data on Monday, February 16th. The company reported GBX (0.10) earnings per share for the quarter. Physiomics had a negative return on equity of 89.43% and a negative net margin of 50.92%. As a group, equities analysts predict that Physiomics Plc will post -0.13 EPS for the current year.

About Physiomics

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.